BahteSKHissMLichtinghagenRKielsteinJT.A missed opportunity: consequences of unknown levetiracetam pharmacokinetics in a peritoneal dialysis patient. BMC Nephrol. 2014;15:49. doi:10.1186/1471-2369-15-49
2.
AronoffGRBennettWMBernsJS, et al.. Drug Prescribing in Renal Failure: Dosing Guidelines for Adults and Children. 5th ed.Philadelphia, PA: American College of Physicians; 2007.
3.
PatsalosPNBerryDJBourgeoisBFDCloydJCGlauserTAJohannessenSI.Antiepileptic drugs: best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring. ILAE Commission on Therapeutic Strategies. Epilepsia. 2008;49:1239-1276.
GlauserTAMitchellWGWeinstockA, et al.. Pharmacokinetics of levetiracetam in infants and young children with epilepsy. Epilepsia. 2007;48:1117-1122. doi:10.1111/j.1528-1167.2007.01090.x
6.
PellockJMGlauserTABebinEM, et al.. Pharmacokinetic study of levetiracetam in children. Epilepsia. 2001;42:1574-1579.